Britney Fontenot
Physician Assistant · Ville Platte, LANPI 1790968832
Payments from drug & device makers
Across 322 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$912
- Sumitomo Pharma America, Inc.$566
- Novo Nordisk$511
- Takeda Pharmaceuticals U.S.A., Inc.$340
- AstraZeneca$330
- Boehringer Ingelheim$272
- plus $2K from 34 others
What the payments were for
- Food & beverage$5,214100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,214 in reported general payments places this provider in the 90th percentile of 1,246 physician assistant providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $67,564 |
| MounjaroTirzepatide | 56 | $58,697 |
| JardianceEmpagliflozin | 89 | $58,339 |
| XareltoRivaroxaban | 32 | $23,804 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $19,527 |
| TradjentaLinagliptin | 17 | $17,188 |
| JanuviaSitagliptin Phosphate | 23 | $15,831 |
| EliquisApixaban | 27 | $15,663 |
| FarxigaDapagliflozin Propanediol | 21 | $15,350 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $11,533 |
| Bydureon BciseExenatide Microspheres | 11 | $9,128 |
| RexultiBrexpiprazole | 13 | $8,520 |
| EntrestoSacubitril/Valsartan | 12 | $8,267 |
| RybelsusSemaglutide | 11 | $4,797 |
| GemtesaVibegron | 16 | $4,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $272 | $75,526106 claims |
| Novo NordiskOzempic, Rybelsus | $511 | $72,36180 claims |
| Lilly USA, LLCMounjaro | $263 | $58,69756 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $330 | $34,87745 claims |
| Johnson & JohnsonXarelto | $28 | $23,80432 claims |
| PfizerEliquis, Premarin | $192 | $18,16339 claims |
| MerckJanuvia | $103 | $15,83123 claims |
| GSKBreo Ellipta | $118 | $11,53329 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $241 | $8,52013 claims |
| NovartisEntresto | $12 | $8,26712 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $566 | $4,13716 claims |
| Eisai Inc.Dayvigo | $25 | $3,96111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,246 physician assistant providers in Louisiana.
Other physician assistant in Ville Platte
- Shelly EsnardBaton Rouge$141K
- Jefferson OberleNew Orleans$66K
- Jennifer ScheuermannNew Orleans$56K
- Claire DarreJefferson$50K
- Elizabeth ClementNew Orleans$35K
- Mary Negrotto GuntherSlidell$29K
- Kristen HebertZachary$27K
- David GsellNew Orleans$26K
- Nakia BrooksNew Orleans$25K
- Savannah SanchezBaton Rouge$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.